Does BOTULINUM TOXIN TYPE A Cause Arthropathy? 573 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 573 reports of Arthropathy have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 15.3% of all adverse event reports for BOTULINUM TOXIN TYPE A.
573
Reports of Arthropathy with BOTULINUM TOXIN TYPE A
15.3%
of all BOTULINUM TOXIN TYPE A reports
568
Deaths
508
Hospitalizations
How Dangerous Is Arthropathy From BOTULINUM TOXIN TYPE A?
Of the 573 reports, 568 (99.1%) resulted in death, 508 (88.7%) required hospitalization, and 517 (90.2%) were considered life-threatening.
Is Arthropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 573 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Arthropathy?
ETANERCEPT (11,842)
ADALIMUMAB (11,670)
ABATACEPT (11,099)
METHOTREXATE (10,973)
TOCILIZUMAB (9,816)
LEFLUNOMIDE (9,277)
HYDROXYCHLOROQUINE (8,770)
RITUXIMAB (8,619)
INFLIXIMAB (8,410)
SULFASALAZINE (7,545)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Arthropathy Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE